ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PEN Penumbra Inc

187.78
-0.22 (-0.12%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 203,456
Bid Price
Ask Price
News -
Day High 188.47

Low
180.93

52 Week Range

High
348.67

Day Low 185.095
Share Name Share Symbol Market Stock Type
Penumbra Inc PEN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-0.22 -0.12% 187.78 16:30:00
Open Price Low Price High Price Close Price Previous Close
187.47 185.095 188.47 187.78 188.00
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
6,607 203,456 US$ 187.46 US$ 38,139,896 - 180.93 - 348.67
Last Trade Type Quantity Price Currency
18:00:00 29,578 US$ 187.78 USD

Penumbra Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.27B 38.70M - 1.06B 90.95M 2.35 79.88
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Penumbra News

Date Time Source News Article
6/07/202415:33Edgar (US Regulatory)Form 8-K - Current report
6/05/202418:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202415:30PR Newswire (US)Penumbra, Inc. to Present at the Truist Securities MedTech..
6/03/202416:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/31/202415:39Edgar (US Regulatory)Form SD - Specialized disclosure report
5/23/202415:30PR Newswire (US)Penumbra, Inc. to Present at the William Blair Growth Stock..
5/22/202418:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/20/202415:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/15/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202418:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/07/202415:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202415:14Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PEN Message Board. Create One! See More Posts on PEN Message Board See More Message Board Posts

Historical PEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week191.71198.48184.10189.25403,335-3.93-2.05%
1 Month201.50204.12184.10191.89314,175-13.72-6.81%
3 Months227.47228.76184.10205.65342,246-39.69-17.45%
6 Months244.77277.34184.10227.53339,299-56.99-23.28%
1 Year334.89348.67180.93241.84373,156-147.11-43.93%
3 Years291.10348.67114.865227.47311,642-103.32-35.49%
5 Years163.60348.67107.50212.24357,81124.1814.78%

Penumbra Description

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Your Recent History

Delayed Upgrade Clock